RT 001

Drug Profile

RT 001

Alternative Names: Di-deuterated ethyl linoleate; Di-deuterated linoleic acid ethyl ester; RT001

Latest Information Update: 25 Mar 2017

Price : $50

At a glance

  • Originator Retrotope
  • Class Unsaturated fatty acids
  • Mechanism of Action Fatty acid replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Friedreich's ataxia
  • New Molecular Entity Yes

Highest Development Phases

  • Phase I/II Friedreich's ataxia
  • Preclinical Alzheimer's disease; Parkinson's disease

Most Recent Events

  • 06 Oct 2016 Preclinical trials in Alzheimer's disease in USA (unspecified route) before September 2016
  • 06 Oct 2016 Preclinical trials in Parkinson's disease in USA (unspecified route) before September 2016
  • 06 Oct 2016 Pharmacodynamics data in Friedreich’s ataxia, Parkinson's disease and Alzheimer's disease released by Retrotope
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top